
Go straight to the source
Search PubMed, Europe PMC and ClinicalTrials.gov from one box. Results come from the indexes themselves, newest first, each linked to its original record.
Amiravo's reviewed summary: Pramlintide research reference →
- PubMedReviewResearch Support, Non-U.S. Gov'tAmylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?Lancet (London, England) · 2026 Dec 20
- PubMedPlasma amylin levels in migraine and after erenumab treatment: A REFORM study.Headache · 2026 Oct 13
- PubMedReviewOral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes.2000
- PubMedReviewAdjunctive Treatments for Patients with Type 1 Diabetes Using Automated Insulin Delivery Systems. A Narrative Review.Diabetes technology & therapeutics · 2026 Sep 4
- PubMedReviewAmylin Analogs: The Next Major Class of Weight Loss Therapy: A Review of Experimental Data and Early-Phase Clinical Trials.Diabetes, obesity & metabolism · 2026 Sep
- PubMedReviewMetal-tuned antimicrobial peptides and zincophore pathways: from coordination chemistry to targeted therapeutics.Journal of inorganic biochemistry · 2026 Jul
- PubMedIn vitro metabolic profiling of weight-loss-inducing amylin receptor agonists in the context of preventive doping research.Journal of pharmaceutical and biomedical analysis · 2026 Jun 15
- PubMedReviewPramlintide.2006
- PubMedSystemic Pharmacokinetic Principles of Therapeutic Peptides.Clinical pharmacokinetics · 2026 Apr
- PubMedReviewLong-acting amylin-related peptides as therapies for obesity and type 2 diabetes.Peptides · 2026 Mar
- PubMedReviewAmylin receptors as therapeutic targets in obesity: Emerging peptide-based strategies.Vascular pharmacology · 2026 Mar
- PubMedMulti-Omics discovery and clinical validation of IGFBP2, B2M, and CST3 as a serum biomarker panel for diabetic kidney disease progression.Gene · 2026 Feb 5
- PubMedReviewThe story of amylin: from physiology to therapy.Nature metabolism · 2026 Feb
- PubMedReviewAmylin Revisited: A 5-Year Perspective on Its Emerging Role in the Treatment of Diabesity.Journal of obesity & metabolic syndrome · 2026 Jan 30
- PubMedCase ReportsCase Series of Nizon-Isidor Syndrome by Heterozygous Variants in MED12L With Further Evidence of Mitotic Instability in One Case With Diploid-Triploid Mosaicism.American journal of medical genetics. Part A · 2026 Jan
- PubMedResearch Support, N.I.H., ExtramuralCentral pramlintide administration potently suppresses operant responding for sucrose and locomotor activity in male rats.Physiology & behavior · 2025 Dec 1
- PubMedRandomized Controlled TrialResearch Support, Non-U.S. Gov'tA Pilot Outpatient Assessment of a Fully Closed-Loop Insulin and Pramlintide System.Journal of diabetes science and technology · 2025 Nov
- PubMedReviewNoninsulin Therapies in Management of Type 1 Diabetes.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025 Nov
- PubMedIn silico evaluation of pramlintide dosing algorithms in artificial pancreas systems.Computers in biology and medicine · 2025 Aug
- PubMedReviewAmylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus.Nature reviews. Endocrinology · 2025 Aug
- PubMedIntranasal pramlintide matches intraperitoneal effects on food intake and gastric emptying in mice.Endocrine · 2025 Jul
- PubMedReviewAmylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025 Jun
- PubMedReviewInsulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance.Endocrine reviews · 2025 May 9
- PubMedReviewAmylin and the amylin receptors in migraine: Is there another pathway to target?Cephalalgia : an international journal of headache · 2025 May
- PubMedFusion Outcomes of GLP-1 Agonist Therapy in Multilevel Cervical Spinal Fusion: A Propensity-Matched Analysis.Clinical spine surgery · 2025 May 1
Queries go directly from your browser to NCBI, EMBL-EBI and ClinicalTrials.gov; Amiravo does not store them. Study-type labels come from the indexes and can be wrong. A record's presence says nothing about whether a compound works or is safe. PubMed data via NCBI E-utilities; see NCBI policies.